Objective: To evaluate the usefulness of 2-[18F]-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in IgG4-related disease (IgG4-RD) for the staging of the disease and the followup under treatment.
Methods: All patients included in the French IgG4-RD registry who underwent ≥1 FDG-PET/CT scan were included in the study. Clinical, biologic, pathologic, radiologic, and FDG-PET/CT qualitative and quantitative findings were retrospectively collected and analyzed.
Results: Twenty-one patients were included in the study and 46 FDG-PET/CT examinations were evaluated. At either diagnosis or relapse, all evaluated patients presented abnormal 18F-FDG uptake in typical IgG4-RD localizations. In most cases, FDG-PET/CT was more sensitive than conventional imaging to detect organ involvement, especially in arteries, salivary glands, and lymph nodes. In few cases (small-sized lesions and brain or kidney contiguous lesions), false-negative results were noted. Evaluation before and after treatment showed in most cases a good correlation of FDG-PET/CT results with treatment response and disease activity.
Conclusion: This large retrospective study shows that FDG-PET/CT imaging is useful for the staging of IgG4-RD. Moreover, FDG-PET/CT is useful to assess the response to treatment during followup.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/acr.22058 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer.
Respir Investig
November 2024
Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto City, Kumamoto, 860-8556, Japan.
Article Synopsis
- F-FDG PET/CT is commonly used to monitor non-small cell lung cancer (NSCLC), but its impact on the effectiveness of osimertinib treatment for patients with EGFR mutations is not well understood.
- A study of 74 patients found that those with a higher maximum standardized uptake value (SUVmax) in their primary tumors had shorter progression-free survival (PFS) compared to those with lower SUVmax, although overall survival (OS) remained similar.
- High SUVmax was identified as an independent negative predictor for PFS in patients receiving osimertinib, indicating its potential as a useful marker for treatment outcomes.
Dose estimation in patients from different protocols of 18F-FDG PET/CT studies and analysis of optimization strategies.
Radiat Prot Dosimetry
September 2024
Department of Nuclear Medicine and Molecular Imaging, Advanced Centre for Treatment Research & Education in Cancer, Tata Memorial Centre, Navi Mumbai 410210, India.
This study aimed to evaluate the dose in different protocols of 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (PET/CT) procedure. The retrospective study involves 207 patients with confirmed malignancies who underwent PET/CT. Effective dose (E) from PET was estimated based on injected activity and dose coefficient as per International Commission on Radiation Protection (ICRP) 128.
View Article and Find Full Text PDFRelation of Insulin Resistance to Brain Glucose Metabolism in Fasting and Hyperinsulinemic States: A Systematic Review and Meta-analysis.
J Clin Endocrinol Metab
January 2025
Steno Diabetes Neuro Unit, Translational Type 2 Diabetes Research, Clinical Translational Research, Steno Diabetes Center Copenhagen, 2730 Herlev, Denmark.
Context: Abnormal brain glucose metabolism may cause cognitive disease in type 2 diabetes, yet the relation between insulin resistance and brain glucose metabolism has not been systematically described.
Objective: We evaluated the impact of metabolic condition (fasting vs insulin stimulation, eg, from hyperinsulinemic clamp) on the association between insulin resistance of different etiologies and brain glucose metabolism.
Data Sources: PubMed, Embase, Cochrane Library, and Web of Science were systematically searched from inception until February 2022.
F-FDG accumulation at the early onset of acute exacerbation of idiopathic interstitial pneumonia on F-FDG PET/CT: A case report.
Respirol Case Rep
July 2024
Department of Respiratory Medicine, Kumamoto University Hospital, Faculty of Life Sciences Kumamoto University Kumamoto Japan.
Article Synopsis
- AE-IIPs are serious conditions linked to poor outcomes in patients with idiopathic interstitial pneumonias.
- A unique case study highlights that F-FDG PET/CT imaging was able to detect signs of AE-IIPs in a lung cancer patient just 18 days after a bronchoscopy, prior to respiratory failure.
- This report is the first to examine F-FDG PET/CT findings during the early stages of AE-IIPs, potentially enhancing our understanding of the disease’s mechanisms.
The Prognostic Significance of Tumor SUVmax Value in Pre- and Post-Chemoradiotherapy 18F-FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma.
Niger J Clin Pract
June 2024
Department of Radiation Oncology, Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey.
Background: Some parameters of 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) can predict tumor chemosensitivity and survival in patients with head and neck squamous cell carcinoma (HNSCC).
Aim: The aim of the study was to investigate the prognostic value of pre- and post-treatment maximum standardized uptake values (SUVmax) in 18F-FDG PET/CT imaging for predicting mortality in patients with HNSCC, as well as its prognostic value in terms of disease progression, overall survival (OS), and progression-free survival (PFS).
Methods: This retrospective study included 37 patients with a histopathological diagnosis of HNSCCs between 2015 and 2018.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!